At a glance
- Originator Nippon Kayaku
- Class Cytostatic antibiotics
- Mechanism of Action Squalene synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Jul 1998 No-Development-Reported for Cancer in Japan (unspecified route)
- 29 Apr 1996 Preclinical development for Cancer in Japan (unspecified route)